Seizert Capital Partners LLC Increases Position in CVS Health Co. (NYSE:CVS)

Seizert Capital Partners LLC raised its stake in CVS Health Co. (NYSE:CVS - Free Report) by 3.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 463,819 shares of the pharmacy operator's stock after buying an additional 15,811 shares during the period. Seizert Capital Partners LLC's holdings in CVS Health were worth $29,165,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of CVS. Capital World Investors boosted its position in CVS Health by 8.0% during the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator's stock worth $3,491,643,000 after purchasing an additional 3,232,172 shares in the last quarter. Capital International Investors grew its stake in CVS Health by 12.5% in the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator's stock valued at $3,024,334,000 after acquiring an additional 4,226,225 shares during the last quarter. Capital Research Global Investors increased its holdings in CVS Health by 1.4% during the 1st quarter. Capital Research Global Investors now owns 13,143,822 shares of the pharmacy operator's stock valued at $1,048,351,000 after acquiring an additional 184,297 shares in the last quarter. Pzena Investment Management LLC lifted its holdings in shares of CVS Health by 132.9% in the second quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator's stock valued at $764,023,000 after purchasing an additional 7,382,931 shares in the last quarter. Finally, Lazard Asset Management LLC grew its position in shares of CVS Health by 5.9% in the first quarter. Lazard Asset Management LLC now owns 6,963,508 shares of the pharmacy operator's stock valued at $555,406,000 after purchasing an additional 389,166 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 3.4 %

CVS traded down $1.90 during trading on Friday, hitting $53.19. 16,695,415 shares of the company's stock were exchanged, compared to its average volume of 13,766,502. The stock has a 50 day moving average price of $59.23 and a 200 day moving average price of $58.66. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $66.93 billion, a P/E ratio of 13.50, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The firm's quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts expect that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio is presently 67.51%.

Analysts Set New Price Targets

A number of research firms recently issued reports on CVS. Barclays reduced their target price on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. TD Cowen raised CVS Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $59.00 to $85.00 in a research note on Friday, October 4th. StockNews.com downgraded shares of CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday. Evercore ISI raised their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Finally, Wells Fargo & Company cut their price objective on shares of CVS Health from $61.00 to $60.00 and set an "equal weight" rating for the company in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $72.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.